

Faron Pharmaceuticals Pleased With Clevegen Clinical Trial Performance


Faron Pharmaceuticals Inks Share Liquidity Pact With Lago Kapital


Faron Pharmaceuticals Says US Regulator Approves Clevegen Drug Status


Faron Pharmaceuticals Applies For Nasdaq First North Growth Listing


UK WINNERS & LOSERS SUMMARY: Games Workshop And Beazley Top FTSE 250


Faron Pharmaceuticals Opens Private Placing To Fund Clevegen Progress


LONDON MARKET CLOSE: Upbeat Global Data Promotes Strong End To Week


Faron Pharmaceuticals Unable To Explain Significant Shares Price Surge